OSL:ZLNA - Euronext Oslo - NO0013524942 - Common Stock - Currency: NOK
OSL:ZLNA (6/18/2025, 7:00:00 PM)
13.5
-0.17 (-1.24%)
The current stock price of ZLNA.OL is 13.5 NOK. In the past month the price increased by 1.5%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
1ABBV.MI | ABBVIE INC | 18.61 | 293.65B | ||
4AB.DE | ABBVIE INC | 17.98 | 283.33B | ||
AMG.DE | AMGEN INC | 13.95 | 135.29B | ||
GIS.DE | GILEAD SCIENCES INC | 14.08 | 117.83B | ||
VX1.DE | VERTEX PHARMACEUTICALS INC | N/A | 99.95B | ||
1REGN.MI | REGENERON PHARMACEUTICALS | 11.92 | 49.56B | ||
ARGX.BR | ARGENX SE | 101.76 | 28.89B | ||
22UA.DE | BIONTECH SE-ADR | N/A | 21.76B | ||
IDP.DE | BIOGEN INC | 8.05 | 16.21B | ||
1EXEL.MI | EXELIXIS INC | 18.83 | 9.81B | ||
1MRNA.MI | MODERNA INC | N/A | 8.71B | ||
0QF.DE | MODERNA INC | N/A | 8.48B |
Zelluna ASA is a NO-based company operating in Biotechnology industry. The company is headquartered in Oslo, Oslo and currently employs 12 full-time employees. The company went IPO on 2019-06-03. Zelluna ASA, formerly Ultimovacs ASA is a Norway-based pharmaceutical company developing immunotherapies against cancer. The firm develops cell therapies for the treatment of cancer patients. Zelluna ASA deals with eliminate solid cancers by unleashing thel elements of the immune system through pioneering the development of T cell receptor (TCR) guided natural killer (NK) cell therapies. The firm provides benefit to patients, their families and all those around them, by developing therapies that bring together TCR guidance with the effector functions of allogeneic NK cells (TCR-NK) deploying a mechanism of action that has the potential to be both safe and potent. Zelluna ASA operates worldwide.
ZELLUNA ASA
Ullernchausseen 64
Oslo OSLO NO
Employees: 12
Phone: 4741380080
The current stock price of ZLNA.OL is 13.5 NOK. The price decreased by -1.24% in the last trading session.
The exchange symbol of ZELLUNA ASA is ZLNA and it is listed on the Euronext Oslo exchange.
ZLNA.OL stock is listed on the Euronext Oslo exchange.
9 analysts have analysed ZLNA.OL and the average price target is 25.5 NOK. This implies a price increase of 88.89% is expected in the next year compared to the current price of 13.5. Check the ZELLUNA ASA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ZELLUNA ASA (ZLNA.OL) has a market capitalization of 273.11M NOK. This makes ZLNA.OL a Micro Cap stock.
ZELLUNA ASA (ZLNA.OL) currently has 12 employees.
ZELLUNA ASA (ZLNA.OL) has a support level at 12.8 and a resistance level at 14.09. Check the full technical report for a detailed analysis of ZLNA.OL support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ZLNA.OL does not pay a dividend.
ZELLUNA ASA (ZLNA.OL) will report earnings on 2025-08-20.
ZELLUNA ASA (ZLNA.OL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-55.48).
ChartMill assigns a technical rating of 4 / 10 to ZLNA.OL.
ChartMill assigns a fundamental rating of 2 / 10 to ZLNA.OL. The financial health of ZLNA.OL is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months ZLNA.OL reported a non-GAAP Earnings per Share(EPS) of -55.48. The EPS decreased by -7.34% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -121.94% | ||
ROE | -162.76% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 42% to ZLNA.OL. The Buy consensus is the average rating of analysts ratings from 9 analysts.